PubRank

Bart J Currie

Author PubWeight™ 250.45‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Melioidosis: epidemiology, pathophysiology, and management. Clin Microbiol Rev 2005 14.71
2 Melioidosis. N Engl J Med 2012 6.94
3 Development and evaluation of a real-time PCR assay targeting the type III secretion system of Burkholderia pseudomallei. J Clin Microbiol 2006 2.94
4 Phylogeographic reconstruction of a bacterial species with high levels of lateral gene transfer. BMC Biol 2009 2.94
5 Nonrandom distribution of Burkholderia pseudomallei clones in relation to geographical location and virulence. J Clin Microbiol 2006 2.34
6 Acute rheumatic fever: a chink in the chain that links the heart to the throat? Lancet Infect Dis 2004 2.33
7 Management of accidental laboratory exposure to Burkholderia pseudomallei and B. mallei. Emerg Infect Dis 2008 2.24
8 Clinical toxinology--where are we now? J Toxicol Clin Toxicol 2003 2.23
9 Community-associated strains of methicillin-resistant Staphylococcus aureus and methicillin-susceptible S. aureus in indigenous Northern Australia: epidemiology and outcomes. J Infect Dis 2009 2.20
10 Scabies: a ubiquitous neglected skin disease. Lancet Infect Dis 2006 2.18
11 Low rates of streptococcal pharyngitis and high rates of pyoderma in Australian aboriginal communities where acute rheumatic fever is hyperendemic. Clin Infect Dis 2006 1.94
12 Isolates of Burkholderia pseudomallei from Northern Australia are distinct by multilocus sequence typing, but strain types do not correlate with clinical presentation. J Clin Microbiol 2004 1.88
13 Indirect hemagglutination assay in patients with melioidosis in northern Australia. Am J Trop Med Hyg 2006 1.82
14 A horizontal gene transfer event defines two distinct groups within Burkholderia pseudomallei that have dissimilar geographic distributions. J Bacteriol 2007 1.82
15 Genomic islands from five strains of Burkholderia pseudomallei. BMC Genomics 2008 1.82
16 Problems in diagnosing scabies, a global disease in human and animal populations. Clin Microbiol Rev 2007 1.81
17 Murray Valley encephalitis: a review of clinical features, diagnosis and treatment. Med J Aust 2012 1.77
18 Antifungal therapy and management of complications of cryptococcosis due to Cryptococcus gattii. Clin Infect Dis 2013 1.76
19 Landscape changes influence the occurrence of the melioidosis bacterium Burkholderia pseudomallei in soil in northern Australia. PLoS Negl Trop Dis 2009 1.74
20 Systematic review and consensus guidelines for environmental sampling of Burkholderia pseudomallei. PLoS Negl Trop Dis 2013 1.72
21 Within-host evolution of Burkholderia pseudomallei over a twelve-year chronic carriage infection. MBio 2013 1.66
22 A randomized controlled trial of granulocyte colony-stimulating factor for the treatment of severe sepsis due to melioidosis in Thailand. Clin Infect Dis 2007 1.64
23 Sensitive and specific molecular detection of Burkholderia pseudomallei, the causative agent of melioidosis, in the soil of tropical northern Australia. Appl Environ Microbiol 2007 1.62
24 Pulmonary manifestations of uncomplicated falciparum and vivax malaria: cough, small airways obstruction, impaired gas transfer, and increased pulmonary phagocytic activity. J Infect Dis 2002 1.60
25 Clinical features and epidemiology of melioidosis pneumonia: results from a 21-year study and review of the literature. Clin Infect Dis 2011 1.57
26 Genetic diversity of Burkholderia pseudomallei isolates in Australia. J Clin Microbiol 2007 1.56
27 Dengue and climate change in Australia: predictions for the future should incorporate knowledge from the past. Med J Aust 2009 1.55
28 Irukandji syndrome case series from Australia's Tropical Northern Territory. Ann Emerg Med 2009 1.54
29 Tandem repeat regions within the Burkholderia pseudomallei genome and their application for high resolution genotyping. BMC Microbiol 2007 1.54
30 Vibrio vulnificus and V. parahaemolyticus necrotising fasciitis in fishermen visiting an estuarine tropical northern Australian location. J Infect 2006 1.51
31 Disease burden and health-care clinic attendances for young children in remote aboriginal communities of northern Australia. Bull World Health Organ 2008 1.51
32 A very early-branching Staphylococcus aureus lineage lacking the carotenoid pigment staphyloxanthin. Genome Biol Evol 2011 1.51
33 Clonality and recombination in genetically differentiated subgroups of Cryptococcus gattii. Eukaryot Cell 2005 1.48
34 Accuracy of Burkholderia pseudomallei identification using the API 20NE system and a latex agglutination test. J Clin Microbiol 2007 1.48
35 Workshop on treatment of and postexposure prophylaxis for Burkholderia pseudomallei and B. mallei Infection, 2010. Emerg Infect Dis 2012 1.48
36 Outcomes of patients with melioidosis treated with meropenem. Antimicrob Agents Chemother 2004 1.48
37 Cutaneous melioidosis in the tropical top end of Australia: a prospective study and review of the literature. Clin Infect Dis 2008 1.48
38 Adjunctive granulocyte colony-stimulating factor for treatment of septic shock due to melioidosis. Clin Infect Dis 2003 1.44
39 Extreme weather events and environmental contamination are associated with case-clusters of melioidosis in the Northern Territory of Australia. Int J Epidemiol 2005 1.43
40 Use of a single-nucleotide polymorphism genotyping system to demonstrate the unique epidemiology of methicillin-resistant Staphylococcus aureus in remote aboriginal communities. J Clin Microbiol 2006 1.43
41 Is Streptococcus pyogenes resistant or susceptible to trimethoprim-sulfamethoxazole? J Clin Microbiol 2012 1.42
42 Pneumonia risk stratification in tropical Australia: does the SMART-COP score apply? Med J Aust 2010 1.41
43 VNTR analysis of selected outbreaks of Burkholderia pseudomallei in Australia. Infect Genet Evol 2006 1.40
44 Community-acquired bacteremic Acinetobacter pneumonia in tropical Australia is caused by diverse strains of Acinetobacter baumannii, with carriage in the throat in at-risk groups. J Clin Microbiol 2002 1.39
45 Lipopolysaccharide heterogeneity among Burkholderia pseudomallei from different geographic and clinical origins. Am J Trop Med Hyg 2006 1.39
46 Melioidosis in northern Australia, 2001-02. Commun Dis Intell Q Rep 2003 1.37
47 A regional initiative to reduce skin infections amongst aboriginal children living in remote communities of the Northern Territory, Australia. PLoS Negl Trop Dis 2009 1.35
48 Cystic Fibrosis and Burkholderia pseudomallei Infection: An Emerging Problem? Clin Infect Dis 2002 1.35
49 Clinical correlates of Panton-Valentine leukocidin (PVL), PVL isoforms, and clonal complex in the Staphylococcus aureus population of Northern Australia. J Infect Dis 2010 1.29
50 Scabies: new future for a neglected disease. Adv Parasitol 2004 1.29
51 Melioidosis at Royal Darwin Hospital in the big 2009-2010 wet season: comparison with the preceding 20 years. Med J Aust 2012 1.29
52 Burkholderia pseudomallei genome plasticity associated with genomic island variation. BMC Genomics 2008 1.28
53 Group A streptococci from a remote community have novel multilocus genotypes but share emm types and housekeeping alleles with isolates from worldwide sources. J Infect Dis 2004 1.27
54 Challenging perceptions of non-compliance with rheumatic fever prophylaxis in a remote Aboriginal community. Med J Aust 2006 1.27
55 Epidemiology of Streptococcus dysgalactiae subsp. equisimilis in tropical communities, Northern Australia. Emerg Infect Dis 2007 1.26
56 Epidemiology of community-acquired and nosocomial bloodstream infections in tropical Australia: a 12-month prospective study. Trop Med Int Health 2004 1.24
57 Clinical definitions of melioidosis. Am J Trop Med Hyg 2013 1.24
58 Inter-species genetic movement may blur the epidemiology of streptococcal diseases in endemic regions. Microbes Infect 2005 1.22
59 Clinical evaluation of a type III secretion system real-time PCR assay for diagnosing melioidosis. J Clin Microbiol 2006 1.20
60 Prevalence and sequence diversity of a factor required for actin-based motility in natural populations of Burkholderia species. J Clin Microbiol 2008 1.18
61 Global implications of the emergence of community-associated methicillin-resistant Staphylococcus aureus in Indigenous populations. Clin Infect Dis 2008 1.16
62 Contamination of hand wash detergent linked to occupationally acquired melioidosis. Am J Trop Med Hyg 2004 1.16
63 Surface analyses and immune reactivities of major cell wall-associated proteins of group a streptococcus. Infect Immun 2005 1.14
64 Phylogenetically distinct Staphylococcus aureus lineage prevalent among indigenous communities in northern Australia. J Clin Microbiol 2009 1.14
65 Scabies: a suitable case for a global control initiative. Curr Opin Infect Dis 2013 1.13
66 Diversity of 16S-23S rDNA internal transcribed spacer (ITS) reveals phylogenetic relationships in Burkholderia pseudomallei and its near-neighbors. PLoS One 2011 1.13
67 Burkholderia pseudomallei in unchlorinated domestic bore water, Tropical Northern Australia. Emerg Infect Dis 2011 1.13
68 Recovery of a Burkholderia thailandensis-like isolate from an Australian water source. BMC Microbiol 2008 1.12
69 BurkDiff: a real-time PCR allelic discrimination assay for Burkholderia pseudomallei and B. mallei. PLoS One 2010 1.11
70 Circulating IgE in patients with ordinary and crusted scabies. J Med Entomol 2004 1.11
71 Scabies: molecular perspectives and therapeutic implications in the face of emerging drug resistance. Future Microbiol 2008 1.10
72 Mechanisms for a novel immune evasion strategy in the scabies mite sarcoptes scabiei: a multigene family of inactivated serine proteases. J Invest Dermatol 2003 1.10
73 Plasminogen binding by group A streptococcal isolates from a region of hyperendemicity for streptococcal skin infection and a high incidence of invasive infection. Infect Immun 2004 1.09
74 Recurrent melioidosis in the Darwin Prospective Melioidosis Study: improving therapies mean that relapse cases are now rare. J Clin Microbiol 2013 1.08
75 Expression of resistance-nodulation-cell-division efflux pumps in commonly used Burkholderia pseudomallei strains and clinical isolates from northern Australia. Trans R Soc Trop Med Hyg 2008 1.08
76 Clonality and α-a recombination in the Australian Cryptococcus gattii VGII population--an emerging outbreak in Australia. PLoS One 2011 1.08
77 Out of the ground: aerial and exotic habitats of the melioidosis bacterium Burkholderia pseudomallei in grasses in Australia. Environ Microbiol 2011 1.08
78 Characterization of ceftazidime resistance mechanisms in clinical isolates of Burkholderia pseudomallei from Australia. PLoS One 2012 1.07
79 Consensus guidelines for dosing of amoxicillin-clavulanate in melioidosis. Am J Trop Med Hyg 2008 1.07
80 Short report: application of a polymerase chain reaction to detect Burkholderia pseudomallei in clinical specimens from patients with suspected melioidosis. Am J Trop Med Hyg 2005 1.07
81 Acute post-streptococcal glomerulonephritis in the Northern Territory of Australia: a review of 16 years data and comparison with the literature. Am J Trop Med Hyg 2011 1.05
82 Prostatic abscess due to Burkholderia pseudomallei: 81 cases from a 19-year prospective melioidosis study. J Urol 2009 1.05
83 Skin disorders, including pyoderma, scabies, and tinea infections. Pediatr Clin North Am 2009 1.03
84 Fibronectin-binding protein gene recombination and horizontal transfer between group A and G streptococci. J Clin Microbiol 2004 1.03
85 Generation and characterization of cDNA clones from Sarcoptes scabiei var. hominis for an expressed sequence tag library: identification of homologues of house dust mite allergens. Am J Trop Med Hyg 2003 1.03
86 Molecular investigations of a locally acquired case of melioidosis in Southern AZ, USA. PLoS Negl Trop Dis 2011 1.03
87 Intersexual variations in Northern (Missulena pruinosa) and Eastern (M. bradleyi) mouse spider venom. Toxicon 2008 1.02
88 Current use of Australian snake antivenoms and frequency of immediate-type hypersensitivity reactions and anaphylaxis. Med J Aust 2008 1.02
89 Factors supporting sustainability of a community-based scabies control program. Australas J Dermatol 2002 1.01
90 B-cell antigen D8/17 is a marker of rheumatic fever susceptibility in Aboriginal Australians and can be tested in remote settings. Med J Aust 2006 1.01
91 Molecular characterization of clinical Burkholderia pseudomallei isolates from India. Am J Trop Med Hyg 2011 1.01
92 Practical challenges of conducting research into rheumatic fever in remote Aboriginal communities. Med J Aust 2006 1.00
93 Acaricidal activity of Melaleuca alternifolia (tea tree) oil: in vitro sensitivity of sarcoptes scabiei var hominis to terpinen-4-ol. Arch Dermatol 2004 1.00
94 Recovering streptococci from the throat, a practical alternative to direct plating in remote tropical communities. J Clin Microbiol 2006 1.00
95 The genetic and molecular basis of O-antigenic diversity in Burkholderia pseudomallei lipopolysaccharide. PLoS Negl Trop Dis 2012 0.99
96 Diagnosis and treatment of mycotic aneurysm due to Burkholderia pseudomallei. Clin Infect Dis 2005 0.98
97 Burkholderia pseudomallei strain type, based on pulsed-field gel electrophoresis, does not determine disease presentation in melioidosis. Microbes Infect 2004 0.97
98 Epidemiological tracking and population assignment of the non-clonal bacterium, Burkholderia pseudomallei. PLoS Negl Trop Dis 2011 0.97
99 Use of a variable amplicon typing scheme reveals considerable variation in the accessory genomes of isolates of Burkholderia pseudomallei. J Clin Microbiol 2006 0.96
100 Melioidosis in Birds and Burkholderia pseudomallei Dispersal, Australia. Emerg Infect Dis 2011 0.96
101 A proposed scoring system for predicting mortality in melioidosis. Trans R Soc Trop Med Hyg 2004 0.96
102 Epidemiology and investigation of melioidosis, Southern Arizona. Emerg Infect Dis 2011 0.96
103 Scabies mite inactivated serine protease paralogues are present both internally in the mite gut and externally in feces. Am J Trop Med Hyg 2006 0.95
104 Comparison of TaqMan PCR assays for detection of the melioidosis agent Burkholderia pseudomallei in clinical specimens. J Clin Microbiol 2012 0.95
105 The scourge of scabies. Biologist (London) 2002 0.95
106 Clinical variation in melioidosis in pigs with clonal infection following possible environmental contamination from bore water. Vet J 2006 0.95
107 Increased transcription of Glutathione S-transferases in acaricide exposed scabies mites. Parasit Vectors 2010 0.95
108 Investigating pressure bandaging for snakebite in a simulated setting: bandage type, training and the effect of transport. Emerg Med Australas 2009 0.94
109 Endemic invasive amoebiasis in northern Australia. Med J Aust 2002 0.93
110 Venomous snakebites worldwide with a focus on the Australia-Pacific region: current management and controversies. J Intensive Care Med 2004 0.93
111 Molecular characterisation of a pH-gated chloride channel from Sarcoptes scabiei. Invert Neurosci 2007 0.93
112 Impact of ethnicity and socio-economic status on Staphylococcus aureus bacteremia incidence and mortality: a heavy burden in Indigenous Australians. BMC Infect Dis 2012 0.93
113 Longitudinal evidence of increasing in vitro tolerance of scabies mites to ivermectin in scabies-endemic communities. Arch Dermatol 2009 0.93
114 Biogeography of Burkholderia pseudomallei in the Torres Strait Islands of Northern Australia. J Clin Microbiol 2013 0.92
115 Evolution of sfbI encoding streptococcal fibronectin-binding protein I: horizontal genetic transfer and gene mosaic structure. J Clin Microbiol 2003 0.92
116 Clinic attendances during the first 12 months of life for Aboriginal children in five remote communities of northern Australia. PLoS One 2013 0.92
117 Identification and characterization of Sarcoptes scabiei and Dermatophagoides pteronyssinus glutathione S-transferases: implication as a potential major allergen in crusted scabies. Am J Trop Med Hyg 2005 0.92
118 Bioterrorism, Glanders and melioidosis. Euro Surveill 2005 0.92
119 Ross River virus and Barmah Forest virus infections: a review of history, ecology, and predictive models, with implications for tropical northern Australia. Vector Borne Zoonotic Dis 2008 0.92
120 Burkholderia pseudomallei isolates from Sarawak, Malaysian Borneo, are predominantly susceptible to aminoglycosides and macrolides. Antimicrob Agents Chemother 2013 0.92
121 Randomized, double-blind, placebo-controlled trial of granulocyte colony-stimulating factor in patients with septic shock. Crit Care Med 2008 0.92
122 Cryptococcus infection in tropical Australia. J Clin Microbiol 2004 0.92
123 A model of immunity to Burkholderia pseudomallei: unique responses following immunization and acute lethal infection. Microbes Infect 2005 0.91
124 Transmission of Burkholderia pseudomallei via breast milk in northern Australia. Pediatr Infect Dis J 2004 0.91
125 Towards a rapid molecular diagnostic for melioidosis: Comparison of DNA extraction methods from clinical specimens. J Microbiol Methods 2011 0.91
126 Melioidosis and Aboriginal seasons in northern Australia. Trans R Soc Trop Med Hyg 2008 0.90
127 Melioidosis in New Caledonia. Emerg Infect Dis 2005 0.90
128 Community-acquired pneumonia in northern Australia: low mortality in a tropical region using locally-developed treatment guidelines. Int J Infect Dis 2005 0.90
129 Scabies in animals and humans: history, evolutionary perspectives, and modern clinical management. Ann N Y Acad Sci 2011 0.90
130 Further evaluation of a rapid diagnostic test for melioidosis in an area of endemicity. J Clin Microbiol 2004 0.90
131 Detection of Burkholderia pseudomallei O-antigen serotypes in near-neighbor species. BMC Microbiol 2012 0.89
132 Trough concentrations of vancomycin: adult therapeutic targets are not appropriate for children. Pediatr Infect Dis J 2012 0.89
133 Skin disease in the first two years of life in Aboriginal children in East Arnhem Land. Australas J Dermatol 2011 0.89
134 Antibody responses to Sarcoptes scabiei apolipoprotein in a porcine model: relevance to immunodiagnosis of recent infection. PLoS One 2013 0.88
135 Distribution of Burkholderia pseudomallei in northern Australia, a land of diversity. Appl Environ Microbiol 2014 0.88
136 Predictive indicators for Ross River virus infection in the Darwin area of tropical northern Australia, using long-term mosquito trapping data. Trop Med Int Health 2008 0.88
137 A multigene family of inactivated cysteine proteases in Sarcoptes scabiei. J Invest Dermatol 2004 0.88
138 Endemic melioidosis in residents of desert region after atypically intense rainfall in central Australia, 2011. Emerg Infect Dis 2015 0.87
139 Melioidosis from contaminated bore water and successful UV sterilization. Am J Trop Med Hyg 2013 0.87
140 Rainfall and vector mosquito numbers as risk indicators for mosquito-borne disease in central Australia. Commun Dis Intell Q Rep 2003 0.87
141 Melioidosis as a consequence of sporting activity. Am J Trop Med Hyg 2013 0.87
142 Streptococcal necrotising fasciitis from diverse strains of Streptococcus pyogenes in tropical northern Australia: case series and comparison with the literature. BMC Infect Dis 2004 0.87
143 Development and validation of Burkholderia pseudomallei-specific real-time PCR assays for clinical, environmental or forensic detection applications. PLoS One 2012 0.87
144 A diagnostic test for scabies: IgE specificity for a recombinant allergen of Sarcoptes scabiei. Diagn Microbiol Infect Dis 2011 0.87
145 NAD-glycohydrolase production and speA and speC distribution in Group A streptococcus (GAS) isolates do not correlate with severe GAS diseases in the Australian population. J Clin Microbiol 2002 0.86
146 The challenge of acute rheumatic fever diagnosis in a high-incidence population: a prospective study and proposed guidelines for diagnosis in Australia's Northern Territory. Heart Lung Circ 2005 0.86
147 Impact of single dose azithromycin on group A streptococci in the upper respiratory tract and skin of Aboriginal children. Pediatr Infect Dis J 2002 0.86
148 Neurological and cognitive recovery following abstinence from petrol sniffing. Neuropsychopharmacology 2005 0.86
149 Accurate and rapid identification of the Burkholderia pseudomallei near-neighbour, Burkholderia ubonensis, using real-time PCR. PLoS One 2013 0.86
150 West nile virus (Kunjin subtype) disease in the northern territory of Australia--a case of encephalitis and review of all reported cases. Am J Trop Med Hyg 2011 0.85
151 Complete Genome Sequence of the Encephalomyelitic Burkholderia pseudomallei Strain MSHR305. Genome Announc 2013 0.85
152 Melioidosis--an uncommon but also under-recognized cause of pneumonia in Papua New Guinea. P N G Med J 2012 0.84
153 Cardiac myosin epitopes for monitoring progression of rheumatic fever. Pediatr Infect Dis J 2011 0.84
154 Surprisingly low seroprevalence of Burkholderia pseudomallei in exposed healthy adults in the Darwin region of tropical Australia where melioidosis is highly endemic. Clin Vaccine Immunol 2013 0.84
155 C-reactive protein in the diagnosis of melioidosis. Am J Trop Med Hyg 2004 0.84
156 Diversity of emm sequence types in group A beta-haemolytic streptococci in two remote Northern Territory Indigenous communities: implications for vaccine development. Vaccine 2010 0.83
157 Identification of a homologue of a house dust mite allergen in a cDNA library from Sarcoptes scabiei var hominis and evaluation of its vaccine potential in a rabbit/S. scabiei var. canis model. Am J Trop Med Hyg 2003 0.83
158 Increased allergic immune response to Sarcoptes scabiei antigens in crusted versus ordinary scabies. Clin Vaccine Immunol 2010 0.83
159 Kava hepatotoxicity with Western herbal products: does it occur with traditional kava use? Med J Aust 2003 0.83
160 Clinical effects and antivenom dosing in brown snake (Pseudonaja spp.) envenoming--Australian snakebite project (ASP-14). PLoS One 2012 0.83
161 Fatal community-associated methicillin-resistant Staphylococcus aureus pneumonia after influenza. Med J Aust 2008 0.83
162 The use of positive serological tests as evidence of exposure to Burkholderia pseudomallei. Am J Trop Med Hyg 2011 0.83
163 Reliability of automated biochemical identification of Burkholderia pseudomallei is regionally dependent. J Clin Microbiol 2013 0.83
164 Murray Valley encephalitis in an adult traveller complicated by long-term flaccid paralysis: case report and review of the literature. Trans R Soc Trop Med Hyg 2006 0.82
165 Death adder envenoming causes neurotoxicity not reversed by antivenom--Australian Snakebite Project (ASP-16). PLoS Negl Trop Dis 2012 0.82
166 Trimethopim-sulfamethoxazole compared with benzathine penicillin for treatment of impetigo in Aboriginal children: a pilot randomised controlled trial. J Paediatr Child Health 2010 0.82
167 Whole-Genome Sequences of Five Burkholderia pseudomallei Isolates from Australian Cystic Fibrosis Patients. Genome Announc 2015 0.81
168 Ivermectin worthy of further investigation. Bull World Health Organ 2009 0.81
169 Out of hospital treatment of patients with melioidosis using ceftazidime in 24 h elastomeric infusors, via peripherally inserted central catheters. Trop Med Int Health 2004 0.81
170 Thoracic radiology of infections emerging after natural disasters. J Thorac Imaging 2006 0.81
171 Changes in serial laboratory test results in snakebite patients: when can we safely exclude envenoming? Med J Aust 2010 0.81
172 Prevention of opportunistic infections in immunosuppressed patients in the tropical top end of the Northern Territory. Commun Dis Intell Q Rep 2003 0.81
173 Efficacy of antivenom against the procoagulant effect of Australian brown snake (Pseudonaja sp.) venom: in vivo and in vitro studies. Toxicon 2006 0.81
174 Vancomycin dosing nomogram for haemodialysis patients. Nephrology (Carlton) 2014 0.80
175 A novel clinical grading scale to guide the management of crusted scabies. PLoS Negl Trop Dis 2013 0.80
176 Enzyme immunoassays in brown snake (Pseudonaja spp.) envenoming: detecting venom, antivenom and venom-antivenom complexes. Toxicon 2006 0.80
177 Chlorination and pH of drinking water do not correlate with rates of melioidosis in the Northern Territory, Australia. Trans R Soc Trop Med Hyg 2004 0.80
178 The fibronectin-binding capacity and host cell adherence of Streptococcus pyogenes strains are discordant with each other. Microbes Infect 2004 0.80
179 A national prospective surveillance study of acute rheumatic fever in Australian children. Pediatr Infect Dis J 2013 0.80
180 Saccade and cognitive function in chronic kava users. Neuropsychopharmacology 2003 0.80
181 Melioidosis: a pediatric disease. Pediatr Infect Dis J 2014 0.79
182 Cost-effectiveness analysis of parenteral antimicrobials for acute melioidosis in Thailand. Trans R Soc Trop Med Hyg 2015 0.79
183 The Importance of Scabies Coinfection in the Treatment Considerations for Impetigo. Pediatr Infect Dis J 2016 0.79
184 Hookworm in the Northern Territory: down but not out. Med J Aust 2013 0.79
185 Use of Whole-Genome Sequencing to Link Burkholderia pseudomallei from Air Sampling to Mediastinal Melioidosis, Australia. Emerg Infect Dis 2015 0.79
186 A 16-year prospective study of community-onset bacteremic Acinetobacter pneumonia: low mortality with appropriate initial empirical antibiotic protocols. Chest 2014 0.78
187 A prospective study of neurocognitive changes 15 years after chronic inhalant abuse. Addiction 2013 0.78
188 Suspected snakebite: one year prospective study of emergency department presentations. Emerg Med (Fremantle) 2003 0.78
189 The SMART-COP score performs well for pneumonia risk stratification in Australia's Tropical Northern Territory: a prospective cohort study. Trop Med Int Health 2012 0.78
190 Primary ocular melioidosis due to a single genotype of Burkholderia pseudomallei in two cats from Arnhem Land in the Northern Territory of Australia. J Feline Med Surg 2009 0.78
191 Ethical problems of evaluating a new treatment for melioidosis. BMJ 2003 0.78
192 Spider bites: addressing mythology and poor evidence. Am J Trop Med Hyg 2005 0.78
193 Scrub typhus in the Northern Territory: exceeding the boundaries of Litchfield National Park. Commun Dis Intell Q Rep 2004 0.78
194 Autoantigens identified by screening a human heart cDNA library with acute rheumatic fever sera. Ann N Y Acad Sci 2009 0.78
195 Positive serologic test results for Burkholderia pseudomallei in asymptomatic persons. Am J Trop Med Hyg 2009 0.78
196 Saccade and cognitive impairment associated with kava intoxication. Hum Psychopharmacol 2003 0.77
197 Strongyloides stercoralis infection as a manifestation of immune restoration syndrome? Clin Infect Dis 2005 0.77
198 Autochthonous melioidosis in humans, Madagascar, 2012 and 2013. Emerg Infect Dis 2014 0.77
199 Inhibition of Streptococcus pyogenes adherence to HaCaT cells by a peptide corresponding to the streptococcal fibronectin-binding protein, SfbI, is strain dependent. Microbes Infect 2004 0.77
200 Rapid detection of H and R Panton-Valentine leukocidin isoforms in Staphylococcus aureus by high-resolution melting analysis. Diagn Microbiol Infect Dis 2010 0.77
201 Apparent contrasting rates of pharyngitis and pyoderma in regions where rheumatic heart disease is highly prevalent. Heart Lung Circ 2007 0.77
202 Melioidosis Causing Critical Illness: A Review of 24 Years of Experience From the Royal Darwin Hospital ICU. Crit Care Med 2016 0.77
203 Priapism and Irukandji syndrome. Ann Emerg Med 2010 0.77
204 Variations in the protective immune response against streptococcal superantigens in populations of different ethnicity. Med Microbiol Immunol 2005 0.76
205 Neurological and cognitive impairment associated with leaded gasoline encephalopathy. Drug Alcohol Depend 2004 0.76
206 Serum C-reactive protein and liver disease in patients with melioidosis. Intensive Care Med 2007 0.76
207 Commentary: pressure bandaging for North American snake bite? No! J Med Toxicol 2011 0.76
208 Extensive diversity of Streptococcus pyogenes in a remote human population reflects global-scale transmission rather than localised diversification. PLoS One 2013 0.76
209 Melioidosis and the kidney. Nephrology (Carlton) 2013 0.76
210 Coagulopathy from tiger snake envenoming and its treatment. Pathology 2002 0.75
211 Neurotropic threat characterization of Burkholderia pseudomallei strains. Emerg Infect Dis 2015 0.75
212 An evaluation of a SAFE-style trachoma control program in central Australia. Med J Aust 2003 0.75
213 Strains of Streptococcus pyogenes from severe invasive infections bind HEp2 and HaCaT cells more avidly than strains from uncomplicated infections. J Clin Microbiol 2003 0.75
214 Pressure bandaging for North American snake bite? No! Clin Toxicol (Phila) 2011 0.75
215 Burkholderia pseudomallei sepsis presenting with pericardial effusion and tamponade. Crit Care Resusc 2008 0.75
216 Clinically applicable laboratory end-points for treating snakebite coagulopathy. Pathology 2006 0.75
217 Infectious diseases in Australia - the next decade. Med J Aust 2012 0.75
218 Entomophthoromycosis caused by Basidiobolus ranarum in tropical northern Australia. Pathology 2012 0.75
219 Increased Neurotropic Threat from Burkholderia pseudomallei Strains with a B. mallei-like Variation in the bimA Motility Gene, Australia. Emerg Infect Dis 2017 0.75
220 Occupational infection with herpes simplex virus type 1 after a needlestick injury. Med J Aust 2002 0.75
221 High rate of immediate systemic hypersensitivity reactions to tiger snake antivenom. Med J Aust 2006 0.75
222 Increased anti-saccade latency is an isolated lingering abnormality in Sydenham chorea. J Neuroophthalmol 2009 0.75
223 Hot water immersion <em>v</em> icepacks for treating pain of <em>Chironex fleckeri</em> stings: a randomised controlled trial. Med J Aust 2017 0.75
224 Action is required to reduce kava supply in Arnhem Land . . . again! Med J Aust 2006 0.75
225 World cup fever. Med J Aust 2010 0.75
226 Histoplasmosis in two aboriginal patients from Australia's tropical Northern Territory. Trans R Soc Trop Med Hyg 2006 0.75
227 Should Aboriginals in the "Top End" of the Northern Territory be vaccinated against hepatitis A? 1994. Med J Aust 2014 0.75
228 Use of terbinafine for tinea in Australian Aboriginal communities in the Top End. Australas J Dermatol 2003 0.75